DOI:
10.1055/s-00000175
Arzneimittelforschung
LinksClose Window
References
Friess T, Scheuer W, Hasmann M.
Combination treatment with erlotinib and pertuzumab against humor tumor xenografts is superior to monotherapy.
Clin Cancer Res 2005;
11: 5300-5308
We do not assume any responsibility for the contents of the web pages of other providers.